1. Home
  2. STAG vs KRYS Comparison

STAG vs KRYS Comparison

Compare STAG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stag Industrial Inc.

STAG

Stag Industrial Inc.

HOLD

Current Price

$38.60

Market Cap

7.3B

Sector

Real Estate

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$270.26

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAG
KRYS
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.8B
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
STAG
KRYS
Price
$38.60
$270.26
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$39.20
$297.60
AVG Volume (30 Days)
1.2M
220.6K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
4.07%
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
$845,184,000.00
$389,130,000.00
Revenue This Year
$8.59
$39.88
Revenue Next Year
$9.28
$34.38
P/E Ratio
N/A
$39.08
Revenue Growth
10.14
33.94
52 Week Low
$31.64
$123.03
52 Week High
$39.98
$298.30

Technical Indicators

Market Signals
Indicator
STAG
KRYS
Relative Strength Index (RSI) 61.66 59.98
Support Level $36.80 $255.65
Resistance Level $39.51 $297.14
Average True Range (ATR) 0.65 8.92
MACD 0.28 2.06
Stochastic Oscillator 95.35 85.16

Price Performance

Historical Comparison
STAG
KRYS

About STAG Stag Industrial Inc.

Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: